Dr. Safeer Ashraf, M.D.
What this data tells you about Dr. Ashraf
Dr. Safeer Ashraf is a hematology & oncology in Jacksonville, FL, with 19 years in practice. Based on federal Medicare data, Dr. Ashraf performed 80,331 Medicare services across 2,229 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ashraf received a total of $3,072 from 61 pharmaceutical and/or device companies across 181 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ashraf is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) | 56,250 | $1 | $4 |
| Epoetin alfa injection (Retacrit) for anemia | 7,280 | $6 | $27 |
| Darbepoetin injection (Aranesp) for anemia | 3,700 | $2 | $14 |
| Denosumab injection (Prolia/Xgeva) | 3,600 | $18 | $39 |
| Blood draw (venipuncture) | 1,746 | $8 | $18 |
| Dexamethasone injection (steroid) | 1,557 | $0 | $1 |
| Complete blood count (CBC) with differential | 1,433 | $8 | $41 |
| Office visit, established patient (20-29 min) | 749 | $65 | $104 |
| Injection, granisetron hydrochloride, 100 mcg | 670 | $0 | $41 |
| Office visit, established patient (30-39 min) | 562 | $93 | $162 |
| Anti-nausea injection (Aloxi/palonosetron) | 540 | $1 | $75 |
| Drug injection, under skin or into muscle | 410 | $10 | $42 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 313 | $21 | $90 |
| Administration of chemotherapy into vein, 1 hour or less | 234 | $95 | $355 |
| Hospital follow-up visit, moderate complexity | 161 | $61 | $115 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 160 | $46 | $160 |
| Infusion into a vein for hydration, each additional hour | 144 | $10 | $40 |
| Infusion, normal saline solution , 1000 cc | 132 | $2 | $97 |
| Infusion into a vein for hydration, 31-60 minutes | 115 | $24 | $130 |
| Prothrombin time test (blood clotting) | 113 | $4 | $28 |
| Administration of chemotherapy into vein, each additional hour | 94 | $21 | $80 |
| Initial hospital admission, moderate complexity | 64 | $98 | $225 |
| Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | 60 | $71 | $70 |
| Injection, diphenhydramine hcl, up to 50 mg | 52 | $1 | $4 |
| Collection of blood sample from implanted device | 46 | $19 | $45 |
| Office visit, established patient, complex (40-54 min) | 41 | $135 | $235 |
| Injection of additional new drug or substance into vein | 35 | $12 | $55 |
| New patient office visit (45-59 min) | 24 | $124 | $265 |
| New patient office visit (30-44 min) | 22 | $84 | $181 |
| Office visit, established patient (10-19 min) | 13 | $37 | $74 |
| Initial hospital admission, high complexity | 11 | $129 | $330 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
4.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ashraf is a mixed practice specialist, with above-average Medicare volume (top 10% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ashraf experienced with iron infusion (injectafer)?
Does Dr. Ashraf receive payments from pharmaceutical companies?
How do Dr. Ashraf's costs compare to other hematology & oncologys in Jacksonville?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology